We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).
Soulskill from the are-you-saying-that-killing-people-has-consequences dept.
ananyo writes "Allen Nicklasson has had a temporary reprieve. Scheduled to be executed by lethal injection in Missouri on 23 October, the convicted killer was given a stay of execution by the state's governor, Jay Nixon, on 11 October — but not because his guilt was in doubt. Nicklasson will live a while longer because one of the drugs that was supposed to be used in his execution — a widely used anesthetic called propofol — is at the center of an international controversy that threatens millions of U.S. patients, and affects the way that U.S. states execute inmates. Propofol, used up to 50 million times a year in U.S. surgical procedures, has never been used in an execution. If the execution had gone ahead, U.S. hospitals could have lost access to the drug because 90% of the U.S. supply is made and exported by a German company subject to European Union regulations that restrict the export of medicines and devices that could be used for capital punishment or torture. This is not the first time that the E.U.'s anti-death-penalty stance has affected the U.S. supply of anesthetics. Since 2011, a popular sedative called sodium thiopental has been unavailable in the United States. 'The European Union is serious,' says David Lubarsky, head of the anesthesiology department at the University of Miami Miller School of Medicine in Florida. 'They've already shown that with thiopental. If we go down this road with propofol, a lot of good people who need anesthesia are going to be harmed.'"
"It ain't so much the things we don't know that get us in trouble. It's the
things we know that ain't so."
-- Artemus Ward aka Charles Farrar Brown